Important Safety Information | NIOX VERO® User Manual (PDF)

For Healthcare Professionals Only

EN

Distributors

Over 24 years of innovation

Take a scroll through our deep routed passion for improving asthma diagnosis and management.

2021
20-08-2019
Technology Awards: Winner

NIOX VERO® is named Most Innovative Asthma Management Technology 2021 at the Global Health and Pharma Awards.

2021
20-08-2019
Healthcare and Pharmaceutical Awards: Winner

NIOX VERO® wins for Circassia as the company takes home Global Leaders in FeNO Testing 2021 at the Global Health and Pharma Awards.

2021
20-08-2019
40 million FeNO tests with NIOX®

Over 40 million FeNO tests have been performed with NIOX® technology, a major milestone.

2020
20-08-2019
MedTech Award: Winner

NIOX VERO® wins MedTech Award for the Most Advanced Asthma Solution 2020

2019
20-08-2019
ARTP Award: Winner

NIOX VERO® maker Circassia wins Small Diagnostic Manufacturer of the Year 2019 from the Association for Respiratory Technology and Physiology (ARTP).

2018
20-08-2018
FeNO testing recognised in GINA

For the first time, GINA recognises the importance of FeNO testing to help assess the Type 2 phenotype and select the right biologic in severe asthma patients.

2017
20-08-2019
NIOX® Nasal introduced for nNO testing

NIOX VERO® introduces the nasal application for the measurement of nNO, bringing new options for the diagnosis of primary ciliary dyskinesia (PCD).

2013
20-08-2019
NIOX VERO® launched

NIOX VERO® comes to market, introducing the breathing handle for the most convenient FeNO testing experience.

2011
20-08-2019
ATS guidelines on interpreting FeNO: 83% of trial patients used NIOX®

The ATS issues guidelines on interpreting FeNO levels derived from clinical studies in which 83% of participants tested with NIOX® technology.

2005
20-08-2019
ERS/ATS joint recommendation on NO measurement

The European Respiratory Society (ERS) and the American Thoracic Society (ATS) publish a joint recommendation on the standardisation of FeNO and nasal NO (nNO) measurement techniques.

2005
20-08-2019
NIOX MINO® launched

The introduction of NIOX MINO® offers users a hand-held, portable FeNO analyser for the first time.

2003
20-08-2019
NIOX FLEX® approved in US

NIOX FLEX® is cleared by the US Food and Drug Administration for monitoring asthma.

2000
20-08-2019
NIOX FLEX® approved in Europe

NIOX FLEX® receives approval as a medical device in Europe, enhancing testing capabilities for healthcare professionals in the diagnosis and management of asthma.

1998
20-08-2019
Creation of NIOX®

The first FeNO device for commercial use is created at the Karolinska Institute.

1998
20-08-2019
Nobel Prize for the discovery of NO as a signalling molecule

The Nobel Prize in Physiology or Medicine was awarded for discoveries concerning NO as a signalling molecule.

1994
20-08-2019
Discovery that NO is decreased after steroid therapy in asthma

A reduction in NO after steroid therapy in asthma patients is uncovered for the first time.

1993
20-08-2019
Discovery that NO is increased in asthma patients

Scientists demonstrate that asthma patients exhale increased levels of NO.

1992
20-08-2019
NO is Molecule of the Year

Science magazine names NO its Molecule of the Year, citing the versatility and importance of the gas.

1991
20-08-2019
Discovery that NO is present in exhaled breath

Researchers at the Karolinska Institute in Sweden identified the presence of NO in human lungs.

1989
20-08-2019
Discovery of NO in biology

The importance of nitric oxide was established in the late 1980s when scientists discovered this tiny molecule had signalling properties. Their work would eventually lead to a Nobel Prize.

Get started with NIOX VERO®

Join the thousands of healthcare professionals who have already performed over 40 million FeNO tests with NIOX®, and improve patient outcomes.

Request a Quote

Join the thousands of healthcare professionals testing FeNO with NIOX®

Contact Us

Contact Customer Service to make a general enquiry about NIOX VERO®